COVID-19 Vaccine Janssen and venous thromboembolism, EMA

As part of ongoing safety monitoring of COVID-19 vaccines, PRAC will assess additional data from 2 large trials, which are to be submitted shortly by the marketing authorisation holder, to further evaluate if cases of venous thromboembolism are linked to COVID-19 Vaccine Janssen.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news